Open figure viewer
Three items are highlighted: I. The recall of L‐tryptophan by the USA Food and Drug Administration because of its near certain causal relation to eosinophilia‐myalgia syndrome; II. The reprinting of an important editorial by D.T. Curry expressing concern at the increasing automatonisation of tasks that formerly required the practice of sophisticated human skills; III. A discussion of the human genome project in terms of costs, time, possible benefits and hazards, and public concern.
This content is only available via PDF.
© MCB UP Limited
1990
You do not currently have access to this content.
